Trial Profile
Study to evaluate the Relationship between Astrocytes Activation, Glucose Metabolism and Amyloid using [11C]BU99008 PET in Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs BU 99008 (Primary) ; Florbetaben F18; Fludeoxyglucose F-18
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Diagnostic use
- 04 Oct 2018 New trial record